Amneal Receives U.S. FDA Approval for Brekiya® (dihydroergotamine mesylate) injection for Acute Treatment of Migraine
On May 15, 2025, Amneal Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved Brekiya®…
On May 15, 2025, Amneal Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved Brekiya®…
On May 15, 2025, the World Health Organization (WHO) announced it has published its World health statistics report…
On May 15, 2025, a team at Children’s Hospital of Philadelphia (CHOP) and Penn Medicine announced that a…
On Mar. 14, 2025, Sanofi announced that it plans to invest at least $20 billion in the United…
On May 12, 2025, Roche announced it plans to invest up to $550 million in its Diagnostics site…
On May 12, 2025, Genentech announced plans to invest more than $700 million in a new 700,000 square…
On May 12, 2025, the the Ministry of Health (MoH) of the Kingdom of Saudi Arabia (KSA) reported…
On May 8, 2025, Bill Gates announced that he has decided to give away his money back to…
On May 8, 2025, University of British Columbia (UBC) research has found that your optimal amount of sleep…
On May 7, 2025, Gilead Sciences announced $11 billion in new planned investment in the U.S. to add…
On May 7, 2025, researchers at the University College London (UCL) and King’s College London announced that an…
On May 7, 2025, the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) have published…
On May 6, 2025, UT Southwestern Medical Center and Children’s Health℠ announced a historic nine-figure grant from the Moody Foundation…
On May 5, 2025, The European Union (EU) and France announced half a billion euros worth of incentives…
On May 2, 2025, researchers at the Wellcome Sanger Institute, UCL, and the University of Cambridge announced they…
On May 2, 2025, the Centers for Disease Control reported twelve pediatric deaths associated with seasonal influenza virus…
On May 1, 2025, the U.S. National Institutes of Health (NIH), the world’s largest funder of biomedical research,…
On May 1, 2025, the staff members at the U.S. National Science Foundation (NSF) were told to “stop…
On Apr. 30, 2025, Regulus Therapeutics announced that it has entered into an agreement and plan of merger…
On Apr. 29, 2025, Merck announced the start of construction for a $1 billion, 470,000 square-foot state-of-the-art biologics…
On Apr. 29, 2025, BioMADE announced Maple Grove as the Minnesota site in its national network of bioindustrial…
On Apr. 28, 2025, researchers at King’s College London, the University of Bristol and Great Ormond Street Hospital…
On Apr. 28, 2025, Merck and SpringWorks Therapeutics announced the companies have entered into a definitive agreement for…
On Apr. 26, 2025, the World Health Organization (WHO) reported that Uganda has declared the end of the…
On Apr. 25, 2025, Amgen announced a $900 million expansion of its Ohio biotech manufacturing facility in New…
On Apr. 25, 2025, University of Washington announced that the Memory & Brain Wellness Center at Harborview Medical…
On Apr. 22, 2025, Syngenta announced that its next-generation insecticide Sovrenta® has received pre-qualification by World Health Organization…
On Apr. 22, 2025, Regeneron Pharmaceuticals announced a significant expansion of its manufacturing capacity through a new agreement…
On Apr. 21, 2025, LifeScienceHistory.com published the cartoon: “The National Institutes of Health (NIH) and U.S. Healthcare in…
On Apr. 17, 2025, research-integrity analysts are warning that ‘journal snatchers’ — companies that acquire scholarly journals from…